Open AccessODAC Recommends Withdrawing Approval for Bevacizumab Use in Breast Cancer Treatment
Publication year - 2010
Publication title -
women s health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.363
H-Index - 39
eISSN - 1745-5065
pISSN - 1745-5057
DOI - 10.2217/whe.10.62
Subject(s) - bevacizumab , medicine , breast cancer , cancer , oncology , intensive care medicine , family medicine , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom